期刊文献+

实验用猪胰腺和小肠组织总RNA提取及鉴定 被引量:5

Extraction and appraisement of total RNA of porcine pancreas and small intestine
下载PDF
导出
摘要 目的:探讨提取猪胰腺和小肠组织总RNA并尽量减少RNA降解的方法,为胰腺和小肠组织高质量RNA的提取和进一步研究奠定基础。方法:取新鲜猪胰腺和小肠组织,RNA提取采用酸性一步法。结果:RNA琼脂糖凝胶电泳显示RNA没有明显降解。结论:胰腺和小肠组织RNA酶含量丰富,极易降解RNA。操作速度、RNA提取试剂盒的质量和防止RNA污染的综合措施是成功制备高质量RNA的关键。 Objective: To investigate approaches of extracting total RNA of porcine pancreas and small intestine and at the same time minimizing the denaturation of RNA, and to pave the way for the improved extraction of RNA of pancreas and small intestine later on and further research. Methods :Fresh porcine pancreas and small intestine were used. Acid one step method was applied to extract RNA. Results: Agarose electrophoresis shows there is no obvious denaturation of RNA. Conclusion. Rnase is rich in pancreas and small intestine and may easily denature RNA. The keys in extracting RNA of highquality are the speed of operation, the quality of RNA extraction kit and effective ways to defend RNA from pollution.
出处 《陕西医学杂志》 CAS 北大核心 2005年第10期1182-1184,共3页 Shaanxi Medical Journal
基金 国家自然科学基金项目(基金编号30170917)
关键词 RNA 提取 降解 胰腺 小肠黏膜 总RNA提取 小肠组织 猪胰腺 琼脂糖凝胶电泳 鉴定 RNA Extraction Denaturation Pancreas Small intestine mucosa
  • 相关文献

参考文献9

  • 1唐承薇,韩军.胆囊收缩素对胰腺生理及病理生理的调节作用[J].中华消化杂志,2001,21(1):43-45. 被引量:6
  • 2Rehfeld JF, Sun G, Christensen T. The predominant cholecystokinin in human plasma and intestine is cholecystokinin-33. J Clin Endocrinol Metab, 2001;86(1) : 251.
  • 3Hillingso JG. Accurate measrement of cholecystokinin in plasma. Clin Chem, 1998;44(5): 991.
  • 4樊代明,陈元方,尤涵.第四讲 胃肠肽类激素对消化系统肿瘤生物学行为的调控作用[J].中华消化杂志,1996,16(4):229-231. 被引量:19
  • 5de Weerth A, von Schrenck T, Lohr M. Human pancreatic cancer cell lines express the CCKB receptor. Hepatogastroenterology, 1999; 46 (25): 472.
  • 6Hirata M, Tsuchida A, Iwao T. Cholecystokinin regulates the invasiveness of human pancreatic cancer cell lines via protein kinase C pathway. Int J Oncol,1999;14(6) : 1129.
  • 7Nakamura R, Miyasaka K, Funakoshi A. Basal plasma cholecystokinin levels in digestive diseasescomparison between CCK-8 like bioactivity by bioassay and CCK immunoreactivity by radioimmunoassay. Nippon Shokakibyo Gakkai Zasshi, 1989;86(11) : 2572.
  • 8Hirata M, Itoh M, Tsuchida A. Cholecystokinin receptor antagonist, loxiglumide, inhibits invasiveness of human pancreatic cancer cell lines.FEBS Lett, 1996;383(3) : 241.
  • 9J萨姆布鲁克 EF弗里奇 T曼尼阿蒂斯.分子克隆实验指南[M].北京:科学出版社,2002.870-898.

二级参考文献7

  • 1Li Y,Am J Physiol,1997年,273卷,G679页
  • 2Tang C,Gut,1997年,40卷,267页
  • 3Tang S,Pancreas,1997年,15卷,325页
  • 4Tang S,Pancreas,1997年,15卷,335页
  • 5Tang C,Carcinogenesis,1995年,16卷,2951页
  • 6Reever J R Jr,Ann New York Acad Sci,1994年,713卷,11页
  • 7Walsh J H,Gastroenterology,1982年,82卷,438页

共引文献31

同被引文献42

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部